Genetically altered mice deficient in functional caspase-9

Details Genetically altered mice deficient in functional caspase-9 Genetically altered mice deficient in functional caspase-9

2008-01-29

2008-01-29

Crouch, Deborah (Department: 1632)

Multicellular living organisms and unmodified parts thereof and

Nonhuman animal

Transgenic nonhuman animal

C800S003000, C800S009000, C800S025000

Reexamination Certificate

active

07323616

ABSTRACT:
The invention relates to genetically manipulated animals that are deficient in the expression of Caspase-9, a protein involved in programmed cell death. The invention further relates to methods for preventing specific types of cell death associated with Caspase-9 activation.

REFERENCES:
patent: 6010878 (2000-01-01), Dixit et al.
patent: 6218511 (2001-04-01), Goldmakher et al.
patent: 6294169 (2001-09-01), Dixit et al.
patent: 6605426 (2003-08-01), Goldmakher et al.
patent: 6890721 (2005-05-01), Dixit et al.
patent: 2003/0105046 (2003-06-01), Yuan et al.
patent: 2003/0198949 (2003-10-01), Goldmakher et al.
patent: 2003/0207262 (2003-11-01), Goldmakher et al.
patent: 2005/0089984 (2005-04-01), Dixit et al.
patent: 0808904 (1997-11-01), None
patent: 0842665 (1998-05-01), None
patent: WO96/12025 (1996-04-01), None
patent: WO-97/46663 (1997-12-01), None
patent: WO98/06263 (1998-02-01), None
patent: WO-98/57664 (1998-12-01), None
patent: WO-99/60171 (1999-11-01), None
Strunk et al. (2004) Phenotypic variation resulting from a deficiency of epidermal growth factor receptor in mice is caused by extensive genetic heterogeneity that can be genetically and molecularly partitioned. Gentics 167:1821-1832.
Leneuve et al. (2003) Cre-mediated germline mosaicism:a new transgenic mouse for the selective removal of residual markers from tri-lox conditional alleles. Nucleic Acids Research. 31:1-8.
Sanford et al. (2001) Influence of Genetic Background on knockout mouse phenotypes. Methods Mol. Biol. 158:217-225.
Cameron et al. (1997) Recent Advances in Transgenic Technology. Molecular Biotechnology. 7:253-265.
Wall et al. (1996) Transgenic Livestock: Progress and prospects for the future. Theriogenology 45:57-68.
Houdebine et al. (1994) Production of pharmaceutical proteins from transgenic animals. Journal of Biotechnology. 34:269-287.
Villa et al., “Capases and caspase inhibitors,” TIBS Trends in Biochemical Sciences, 22(10):388-393, (1997).
Duan H. et al., “ICE-LAP6 a novel member of the ICE/Ced-3 gene family.”; J. Bio. Chem; vol. 6, No. 28; Jul. 12, 1996 pp. 16720-16724.
Hakem R. etlal., “Differential requirement for caspase 9..” CELL; Vo. 94, No. 3; Aug. 7, 1998; pp. 339-352.
Kuida K. et al., “Reduced apoptosis and cytochrom c-mediated caspase..”; CELL, vol. 9, No. 3, Aug. 7, 1998; pp. 325-337.
Kuida K. eteal., “Decreased apoptosis in the brain and..” NATURE, vol. 384, No. 6607; Nov. 28, 1996; pp. 368-372.
Li Peng, et al., “Cytochrom c and dATP-dependent formation of..”; CELL, Vo. 91, No. 4.; Nov. 14, 1997; pp. 479-489.
Soengas M.,et al. ; “Apaf-1 and caspase-9 in p53 dependent . . . ”; SCIENCE, Vo. 284, No. 5411; Feb. 4, 1999, pp. 156-159.

Affiliated with

Also associated with

Rating

Genetically altered mice deficient in functional caspase-9 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genetically altered mice deficient in functional caspase-9, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetically altered mice deficient in functional caspase-9 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2810527